美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
41709 A II 2025/03/31 BEIJING GUOWEI BIOTECHNOLOGY CO LTD HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES
41711 A II 2025/03/31 NOVOPROTEIN SCIENTIFIC (HEZE) INC AACAS12BMAX ENHANCED, GMP GRADE
41713 A II 2025/03/31 ACROBIOSYSTEMS CO LTD CYTOPAK™ GMP HUMAN IL-2 PROTEIN (GMP-L02H14GB01)
40997 A IV 2025/03/31 VIKRAM THERMO INDIA LTD DRUGCOAT RL/RS (AMMONIO METHACRYLATE COPOLYMER NF)
41521 A II 2025/03/30 PIRAMAL PHARMA LTD EDOXABAN TOSYLATE MONOHYDRATE
41530 A IV 2025/03/30 DEOSEN BIOCHEMICAL (ORDOS) LTD XANTHAN GUM
41601 A II 2025/03/30 ALIVUS LIFE SCIENCES LTD BUPROPION HYDROBROMIDE
41603 A II 2025/03/30 ALIVUS LIFE SCIENCES LTD FINERENONE
41689 A II 2025/03/30 MAITHRI DRUGS PRIVATE LTD DOXYCYCLINE HYCLATE USP
41288 A II 2025/03/29 OPTIMUS DRUGS PRIVATE LTD EDOXABAN TOSYLATE MONOHYDRATE
41354 A II 2025/03/29 BIOCON LTD NINTEDANIB ESYLATE
41498 A II 2025/03/29 MSN LIFE SCIENCES PRIVATE LTD SPARSENTAN
41502 A II 2025/03/29 EMNAR PHARMA PRIVATE LTD SODIUM VALPROATE
41506 A III 2025/03/29 HUBEI HUAQIANG HIGH-TECH CO LTD HALOGENATED BUTYL RUBBER PLUNGER FOR PREFILLED SYRINGES
41583 A II 2025/03/29 MAITHRI LABORATORIES PRIVATE LTD BETAHISTINE HYDROCHLORIDE USP
41616 A II 2025/03/29 MSN LIFE SCIENCES PRIVATE LTD MARIBAVIR
41636 A II 2025/03/29 MSN LABORATORIES PRIVATE LTD CABOZANTINIB FUMARATE [ROUTE CODE CFR]
41690 A II 2025/03/29 MAITHRI DRUGS PRIVATE LTD DIBASIC SODIUM PHOSPHATE HEPTAHYDRATE USP
41701 A II 2025/03/29 MSN LIFE SCIENCES PRIVATE LTD LISINOPRIL USP
38769 A II 2025/03/28 NEULAND LABORATORIES LTD DABIGATRAN ETEXILATE MESYLATE

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files